Antibody Modification Analysis

CD ComputaBio provides advanced and innovative solutions for antibody analysis and modification to improve the potency, specificity, and therapeutic potential of antibodies. Using state-of-the-art algorithms and cutting-edge methodologies, we offer a range of services to meet the diverse needs of antibody engineering and optimization.

Our Services

Antibody Modification Analysis

  • Antibody Sequence Analysis

Our powerful computational tools analyze antibody sequences to identify potential modification sites such as point mutations, insertions, deletions, or other structural changes. This analysis helps identify critical regions and optimize antibody performance.

  • Epitope Mapping

We offer epitope mapping services to identify specific binding sites on target antigens. With this information, antibody modifications can be rationally designed to improve antigen affinity and selectivity.

  • Protein-Protein Docking

Complex protein-protein docking simulations allow us to predict and analyze the binding interactions between antibodies and their targets. This analysis helps to understand the binding mechanism of the antibody to the target and facilitates targeted antibody modification.

  • Characterization Optimization

We use computational techniques to optimize unique antibody properties such as stability, solubility and anti-aggregation. This ensures that modified antibodies maintain desirable properties while avoiding potential drawbacks.

  • Affinity Maturation

Our services include affinity maturation, a process designed to enhance the binding affinity between an antibody and antigen. Through iterative computational analysis and structural optimization, we can improve the selectivity of an antibody, leading to more precise target recognition.

  • Bispecific Antibody Design

We specialize in designing bispecific antibodies that can target two different antigens simultaneously. Our algorithms and methods allow us to rationalize the design and manufacture of bispecific antibodies with higher therapeutic potential.


Antibody Modification Analysis2

  •  Machine Learning Models

Our computer-aided antibody modification analysis uses advanced machine-learning algorithms. These models are trained on a large amount of antibody sequence and structure data, allowing us to predict the effect of specific modifications on antibody function.

  • Molecular Dynamics Simulation

Using the power of molecular dynamics simulation, we can model antibody-target interactions in a dynamic environment. In this way, we can gain insight into the stability, flexibility, and conformational changes of antibodies after modification.


  • Library Design and Screening

We assist in the design of antibody libraries for phage display or yeast surface display screening. Our expertise helps researchers create diverse libraries to identify novel antibody variants with desired properties.

  • In Silico antibody production

We provide in silico tools for optimizing antibody production, predicting antibody yields, evaluating expression systems, and optimizing post-translational modifications.


  • Accurate and efficient

Our state-of-the-art algorithms and methods ensure accurate analysis, saving time and effort compared to traditional experimental methods. We provide accurate predictions to guide antibody modification strategies.

  • Customized Solutions

We understand that every project is unique, so we offer customized solutions to meet your specific requirements. Our team of experienced scientists works closely with our clients to develop customized strategies to ensure the best results for your research goals.

Why Choose Us?

Our antibody modification analysis service provides state-of-the-art solutions that empower researchers and accelerate the process of antibody engineering. Through advanced algorithms, innovative approaches, and personalized support, we facilitate the optimization of antibodies for improved therapeutic applications. Partner with us to unlock the full potential of antibody engineering and make meaningful advances in biomedicine.

* For Research Use Only.